Chiesi dedicates itself to the research, development and sales of innovative, therapeutic prescription products in the areas ... of respiratory, neonatology, transplant medicine and rare diseases. Chiesi GmbH with its headquarter in Hamburg is a subsidiary of Chiesi Farmaceutici S.p.A, an international and privately-managed pharmaceutical company founded in 1935. Today we employ more than 5.600 people in 28 subsidiaries worldwide and market our products in approximately 70 different countries. In Germany 350 people are employed. In 2018, Chiesi was consecutively honoured as Top Employer by the TOP Employers Institute for the eighth time. “People and ideas for innovation in healthcare” – this is what Chiesi stands for. Our products are innovative at heart. Three of our Drugs are on the World Health Organizations list for essential medicines. One of our goals is to strike out in a new direction. We are proud to have respectively launched the first gene- and stem cell therapy in Europe. One of our drugs is global market leader in neonatology and an essential component in the primary care of premature babies with infant repertory distress syndrome. For further information please visit: Career: www.chiesi.de/en/working-at-chiesi Imprint: Chiesi GmbH Gasstraße 6 22761 Hamburg Tel.: +49 (0)40 897 24-0 Fax: +49 (0)40 897 24-212 info.de(at)chiesi.com Managing Director: Thomas Gauch Commercial register entry: Hamburg County Court HRB 84675 Tax ID No. DE222426963 Competent regulatory authority: Freie und Hansestadt Hamburg Behörde für Gesundheit und Verbraucherschutz Abteilung Pharmaziewesen und Medizinprodukte Billstraße 80 20539 Hamburg read more